[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019

December 2019 | 62 pages | ID: TF73A0AC8D87EN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2019' provides an overview of Tissue Regenerative Materials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Regenerative Materials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Tissue Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Tissue Regenerative Materials Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
3.2 Tissue Regenerative Materials - Pipeline Products by Territory
3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date

4 TISSUE REGENERATIVE MATERIALS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development

5 TISSUE REGENERATIVE MATERIALS COMPANIES AND PRODUCT OVERVIEW

5.1 Biora AB Company Overview
  5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview
5.2 Collagen Matrix Inc Company Overview
  5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Colorado Therapeutics, LLC Company Overview
  5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 credentis AG Company Overview
  5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview
5.5 Gene Techno Science Co Ltd Company Overview
  5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 TISSUE REGENERATIVE MATERIALS- RECENT DEVELOPMENTS

6.1 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication's Industry Relations Committee
6.2 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
6.3 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team
6.4 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28%
6.5 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business
6.6 Jun 19, 2019: CelGro accelerates dental implant treatment
6.7 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update
6.8 May 23, 2019: Full availability of Geistlich Fibro-Gide, the alternative soft-tissue graft
6.9 May 23, 2019: Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets
6.10 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel
6.11 May 16, 2019: CURODONT REPAIR is the superior treatment for white spots
6.12 May 01, 2019: Orthocell submits AUS regulatory application for CelGro
6.13 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter
6.14 Apr 11, 2019: CURODONT REPAIR FLUORIDE PLUS - distribution starts in the US
6.15 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
6.16 Feb 20, 2019: CURODONT PROTECT - Best Prophylaxis during Orthodontic Treatment
6.17 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30%
6.18 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board
6.19 Jan 22, 2019: Straumann Group appoints Alastair Robertson as Head of Global People Management & Development

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
Table 2: Tissue Regenerative Materials - Pipeline Products by Territory
Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Table 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
Table 5: Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
Table 6: Tissue Regenerative Materials - Pipeline Products by Stage of Development
Table 7: Biora AB Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Straumann Emdogain FL - Product Status
Table 9: Straumann Emdogain FL - Product Description
Table 10: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: MatrixMem - Product Status
Table 12: MatrixMem - Product Description
Table 13: Socket Repair Kit - Product Status
Table 14: Socket Repair Kit - Product Description
Table 15: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Xenograft Implant - Dental - Product Status
Table 17: Xenograft Implant - Dental - Product Description
Table 18: credentis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 19: CUROLOX Perio - Product Status
Table 20: CUROLOX Perio - Product Description
Table 21: Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: GCT-101 - Product Status
Table 23: GCT-101 - Product Description
Table 24: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status
Table 26: Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description
Table 27: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Electrospun Scaffold - Product Status
Table 29: Electrospun Scaffold - Product Description
Table 30: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: MaxiGuide - Product Status
Table 32: MaxiGuide - Product Description
Table 33: Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Bone Inductive Implant - Product Status
Table 35: Bone Inductive Implant - Product Description
Table 36: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 37: OrthoNovaOss - Product Status
Table 38: OrthoNovaOss - Product Description
Table 39: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: CelGro - Dental - Product Status
Table 41: CelGro - Dental - Product Description
Table 42: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Inorganic Dental Cement - Product Status
Table 44: Inorganic Dental Cement - Product Description
Table 45: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Soft Tissue Control Implant - Product Status
Table 47: Soft Tissue Control Implant - Product Description
Table 48: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: DentaColl - Product Status
Table 50: DentaColl - Product Description
Table 51: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 52: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status
Table 53: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description
Table 54: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status
Table 56: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description
Table 57: Glossary

LIST OF FIGURES

Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory
Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date

COMPANIES MENTIONED

Biora AB
Collagen Matrix Inc
Colorado Therapeutics, LLC
credentis AG
Gene Techno Science Co Ltd
Histocell SL
Indian Institute of Technology Bombay
Maxigen Biotech Inc
Nobel Biocare Services AG
Novatissue SAS
Orthocell Ltd
Polytechnic University of Catalonia
Straumann Holding AG
SurgaColl Technologies Ltd
SweetBio, Inc.
Tigran Technologies AB


More Publications